-0.00934796763091814 -0.0093014603292717 -0.0093014603292717 -0.0093014603292717 -0.00934796763091814 -0.00483675937122124 0.00074411682634172 -0.0326016184540973
Sign Up Today X
Thanks for submitting the form.
Stockreport

IDbyDNA and Illumina Partner to Deliver NGS Infectious Disease Solutions

Illumina, Inc. (ILMN)  More Company Research Source: Business Wire
Last illumina, inc. earnings: 4/30 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: illumina.com/company/investor-information.html
Partnership Aims to Accelerate NGS Adoption for Clinical Infectious Disease Testing by Combining Comprehensive Sequencing Workflows with Turn-key Clinical Informatics SAN FRANCISCO--(BUSINESS WIRE)--IDbyDNA Inc., a metagenomics technology company setting a standard for detection, identification and interpretation of microorganisms and their role in human health, today announced a global strategic partnership with Illumina, Inc. (Nasdaq: ILMN), to bring comprehensive next-generation sequencing (NGS) based workflows to the global microbiology market.Under the terms of the agreement, Illumina and IDbyDNA will each co-market IDbyDNA’s Explify® Platform for use with Illumina’s NGS systems and library preparation to provide a complete, streamlined workflow solution for infectious disease applications. In addition, IDbyDNA and Illumina will partner to co-develop research use only (RUO) workflows.The partnership aims to enable broad distribution of NGS equipment, library prep, as well as o [Read more]
IMPACT SNAPSHOT EVENT TIME: ILMN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
ILMN alerts
from News Quantified
ILMN
NEWS
ILMN
Earnings
ILMN
Analyst Actions
ILMN
SEC Filings
Stockreport

IDbyDNA and Illumina Partner to Deliver NGS Infectious Disease Solutions

Illumina, Inc.  (ILMN) 
More Company Research Source: Business Wire
Last illumina, inc. earnings: 4/30 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: illumina.com/company/investor-information.html
Partnership Aims to Accelerate NGS Adoption for Clinical Infectious Disease Testing by Combining Comprehensive Sequencing Workflows with Turn-key Clinical Informatics SAN FRANCISCO--(BUSINESS WIRE)--IDbyDNA Inc., a metagenomics technology company setting a standard for detection, identification and interpretation of microorganisms and their role in human health, today announced a global strategic partnership with Illumina, Inc. (Nasdaq: ILMN), to bring comprehensive next-generation sequencing (NGS) based workflows to the global microbiology market.Under the terms of the agreement, Illumina and IDbyDNA will each co-market IDbyDNA’s Explify® Platform for use with Illumina’s NGS systems and library preparation to provide a complete, streamlined workflow solution for infectious disease applications. In addition, IDbyDNA and Illumina will partner to co-develop research use only (RUO) workflows.The partnership aims to enable broad distribution of NGS equipment, library prep, as well as o [Read more]
IMPACT SNAPSHOT
EVENT TIME:
ILMN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS